Schedule / Program

Schedule

Coming soon

Program

Special Lecture

Special Lecture1

scheduleJune 17 Tue. 11:20 - 12:20, Venue A

From abiogenesis to ChatGPT: An emergence after 3.8 billion years.

Speaker
Shinichi Nishikawa
Professor Emeritus of Kyoto University

Special Lecture2

scheduleJune 18 Wed. 11:00 - 12:00, Venue A

Cancer stromal targeting (CAST) therapy

Speaker
Yasuhiro Matsumura
RIN Institute Inc. National Cancer Center Research Institute

Special Event

Coming soon

Presidential Lecture

Coming soon

Symposium

Symposium1

scheduleJune 17 Tue. 9:15 - 11:15, Venue A

AI, Computer Science, and Drug Discovery

Chairs
Hiroshi Tsugawa
Tokyo University of Agriculture and Technology, Department of Biotechnology and Life Science
Masahito Ohue
School of Computing, Institute of Science Tokyo
Speakers

Pattern Recognition of Chemical Structures and ADMET Prediction by Language AI

Tadahaya Mizuno
Graduate School of Pharmaceutical Sciences, The University of Tokyo

Laboratory automation for efficient drug discovery research

Naruki Yoshikawa
Division of Computational Drug Discovery and Design, Medical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo

Data-Driven Approaches in Drug Discovery and Vaccine Development

Yayoi Natsume-Kitatani
Artificial Intelligence Center for Health and Biomedical Research, National Institutes of Biomedical Innovation, Health and Nutrition

Computational mass spectrometry to deepen the understanding of metabolite diversity

Hiroshi Tsugawa
Tokyo University of Agriculture and Technology, Department of Biotechnology and Life Science

AI-driven multimodality drug discovery

Masahito Ohue
School of Computing, Institute of Science Tokyo

Symposium2

scheduleJune 17 Tue. 9:15 - 11:15, Venue B

Chemical and material technologies driving next-generation DDS

Chair
Nobuhiro Nishiyama
Professor, Institute of Integrated Research, Institute of Science Tokyo
Speakers

Therapeutic In Vivo Synthetic Chemistry

Katsunori Tanaka
Department of Chemical Science and Engineering, Institute of Science Tokyo
Biofunctional Synthetic Chemistry laboratory, RIKEN Pioneering Research Institute

JigSAP -Sustained-Release Peptide Hydrogel - for the Treatment of Ischemic Stroke

Itsuki Ajioka
Center for Brain Integration Research (CBIR), Institute of Integrated Research (IIR), Institute of Science Tokyo

Nanomedicines for immunotherapy

Horacio Cabral
Department of Bioengineering, Graduate School of Engineering, The University of Tokyo

Regulation of cellular phenotypes with disk-shaped polymer micro-patches and its application to solid tumor treatment including glioblastoma

Tatsuya Fukuta
Department of Physical Pharmaceutics, School of Pharmaceutical Sciences, Wakayama Medical University

Biomolecule Delivery Systems Based on Combination of Polyphenol and Precision Synthetic Polymers for Potential Application to Gene Therapy

Yuto Honda
Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology

Symposium3

scheduleJune 17 Tue. 9:15 - 11:15, Venue C

Advancements in Antibody–Drug Conjugates and Future Outlook for Next Generation ADCs

Chairs
Shino Manabe
Laboratory of Synthetic Biomolecular Chemistry, School of Pharmacy and Pharmaceutical Sciences, Hoshi University
Koji Abe
Drug Metabolism & Pharmacokinetics Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd.
Speakers

Deepening and Advancing ADC Technology

Shino Manabe
Laboratory of Synthetic Biomolecular Chemistry, School of Pharmacy and Pharmaceutical Sciences, Hoshi University

Applications to Various Antibody Conjugates Using Antibody Site-Specific Conjugation Method AJICAP®

Tomohiro Fujii
Ajinomoto Co., INC

Research and development of antibody-drug conjugates (ADCs) loaded with a potent DNA topoisomerase I inhibitor

Takashi Nakada
Modality Research Laboratories I Research Function R&D Division, Daiichi Sankyo Co., Ltd.

Broad-spectrum efficacy of CEACAM6-targeted antibody–drug conjugate with BET protein degrader in solid tumor mouse models

Hiroyuki Kogai
Cell Lineage & Differentiation Domain, DHBL, Eisai Co. Ltd.

Advance of Cyclic Peptides in Radiopharmaceuticals and Beyond Using PeptiDream's Peptide Drug Platform System (PDPS) Technology

Masato Murakami
Chief Medical Officer of PeptiDream Inc.
President and Representative Director of PDRadiopharma Inc.
Vice President, Japan Radiopharmaceuticals Association (JRPA)

Symposium4

scheduleJune 17 Tue. 13:40 - 15:40, Venue B

The latest technologies of animal alternatives in DDS research

Chairs
Yoshikatsu Koga
Center for Promotion of Translational Research (CPOT), National Cancer Center
Yamamoto Yoshiyuki
Department of gastroenterology, University of Tsukuba
Speakers

Trends of the cosmetics industry's efforts for alternatives to animal experiments

Akiko Tamura
Brand Value R&D Institute, Shiseido Co., Ltd.

Animals and Alternatives to animal experiments - Expectations for the correlation including MPS

Yuzuru Ito
Faculty of Life and Environmental Sciences, University of Tsukuba

Advancement of MPS Research for Animal Alternatives in Pharmaceutical Industry

Wataru Obuchi
Drug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd.

Shaping the Future of Experimental Animals with Mice

Aya Uchida
The Jackson Laboratory Japan, Technical Information Services

Standardization of alternatives to animal testing and the role of JaCVAM

Takao Ashikaga
National Institute of Health Sciences, Division of Genome Safety Science

Symposium5

scheduleJune 17 Tue. 13:40 - 15:40, Venue C

Development of next-generation vaccines and DDS

Chairs
Makiya Nishikawa
Faculty of Pharmaceutical Sciences, Tokyo University of Science
Fuminori Sakurai
Faculty of Pharmacy, Kindai University
Speakers

Development of next-generation vaccines and DDS - What is the role of DDS researchers in the development of next-generation vaccines ? -

Fuminori Sakurai
Faculty of Pharmacy, Kindai University

Next-generation vaccine against novel coronaviruses

Daisuke Muraoka
Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute

Next-generation vaccine development based on DDS for nucleic acid adjuvants and antigens

Makiya Nishikawa
Faculty of Pharmaceutical Sciences, Tokyo University of Science

Utilization of Bacterium-like Particles for Vaccine Antigen Delivery

Keita Takahashi
Gifu Pharmaceutical University, Laboratory of Microbiology and Immunology

Research and Development of mRNA Vaccine “Daichirona”

Toshihiro Kiho
Daiichi-Sankyo R&D Division Vaccine Research Laboratories

Development of Anti-senescence Therapy Targeting Seno-Anergy

Tohru Minamino
Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine

Symposium6

scheduleJune 18 Wed. 8:55 - 10:55, Venue B

Diverse nucleic acid modalities open up new therapeutic strategies

Chairs
Kanjiro Miyata
Graduate School of Engineering, The University of Tokyo
Takashi Nakamura
Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University
Speakers

Development trends and future prospects for nucleic acid-based modalities

Takao Inoue
National Institute of Health Sciences

Anticancer effects of nucleic acid aggregates

Akimitsu Okamoto
Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo

Nucleic acid adjuvant system-based cancer immunotherapy

Takashi Nakamura
Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University

Development of anti-cancer siRNA therapeutics targeting the transcription factor PRDM14, a molecule responsible for cancer stem cell properties.

Hiroaki Taniguchi
Division of Innovative Cancer Control Research, Cancer Research Institute of Kanazawa University

Development of mRNA vaccines and therapeutics against infectious diseases and our efforts toward future clinical translation

Satoshi Uchida
Department of Advanced Nanomedical Engineering, Medical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo

Symposium7

scheduleJune 18 Wed. 8:55 - 10:55, Venue C

New frontiers in radiopharmaceutical development and theranostics

Chairs
Tadashi Watabe
Graduate School of Medicine, The University of Osaka
Hiroki Takashima
Division of Developmental Therapeutics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center
Speakers

Drug Delivery System in radioimmunotherapy with astatine-211

Hiroki Takashima
Division of Developmental Therapeutics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center

Development of Radioisotope Labeling Techniques and Their Application to Radiotheranostic Probes

Hiroyuki Kimura
Agency for Health, Safety and Environment, Kyoto University

Development of radiotheranostic antibody drug for pancreatic cancer and its basic research

Naoaki Yamada
Research Center, Nihon Medi-Physics Co. Ltd.

Preclinical evaluation of Cadherin 3 (CDH3) -targeted alpha particle emitting radiopharmaceutical therapy, 225Ac-PPMX-T002 for the treatment of solid cancer

Shinji Hagiwara
Research and Development Division, Perseus Proteomics Inc.

Targeted alpha therapy using astatine: from preclinical to clinical applications

Tadashi Watabe
Graduate School of Medicine, The University of Osaka

Symposium8

scheduleJune 18 Wed. 15:15 - 17:15, Venue B

Chemical Biology Pioneering New Frontiers of Drug Delivery Systems

Chairs
Kenjiro Hanaoka
Graduate School of Pharmaceutical Sciences, Keio University
Yosuke Demizu
Division of Organic Chemistry, National Institute of Health Sciences
Speakers

Development of a near-infrared (NIR) dye for photoimmunotherapy and its application

Kenjiro Hanaoka
Graduate School of Pharmaceutical Sciences, Keio University

Exosome Hijacking DDS and Light-Triggered Genome Editing

Asako Yamayoshi
Department of Life Science and Technology, Institute of Science Tokyo

Polymer design for enhanced drug delivery

Kanjiro Miyata
Graduate School of Engineering, The University of Tokyo

Molecular targeted chemogenetics: cell-type-specific control of cell-surface receptors in vivo

Shigeki Kiyonaka
Graduate School of Engineering, Nagoya University

Development and Application of DDS Carrier Peptides

Yosuke Demizu
Division of Organic Chemistry, National Institute of Health Sciences

Symposium9

scheduleJune 18 Wed. 15:15 - 17:15, Venue C

Frontiers in antibody engineering for DDS

Chairs
Ryutaro Asano
Dept. of Biotech. & Life Sci., Grad. Sch. of Eng., Tokyo Univ. of Agric. & Tech.
Masahiro Tatsuno
Clinical Pharmacology Deupty Head, Pharmaceutical Science Dept., Chugai Pharmaceutical Co., Ltd.
Speakers

Prodrugation of bispecific antibodies leading to cancer-specific functionalization

Ryutaro Asano
Dept. of Biotech. & Life Sci., Grad. Sch. of Eng., Tokyo Univ. of Agric. & Tech.

Granting BBB-penetrating ability to antibody drugs using LassoGraft technology

Junichi Takagi
Institute for Protein Research, The University of Osaka

Development of antibody-drug conjugates using AccumBody, tissue-specific delivering antibody

Yuji Ito
Department of Science, Graduate School of Science and Engineering, Kagoshima University

Catalytic antibody (Antigenase) directly damaging cancer cell

Emi Hifumi
Institute for Research Management, Oita University

Novel antibody engineering technologies enabling subcutaneous anti-complement C5 antibody therapy

Kenta Haraya
Research Division, Discovery Biologics Department, Chugai Pharmaceutical Co., Ltd.

Clinical development of Crovalimab dosage optimization - beyond the drug-target-drug complex -

Tomohisa Saito
Chugai Pharmaceutical. Co., Ltd. Pharmaceutical Science department

Oral Presentations

Coming soon

Poster Presentations

Coming soon

Luncheon Seminar

Coming soon

General Meeting

Coming soon

Award Ceremony / Award Lecture

Coming soon

Corporate Exhibition Presentations

Coming soon